Page last updated: 2024-12-05
phenoxarsine oxide
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
phenoxarsine oxide: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 6017 |
| SCHEMBL ID | 203388 |
| MeSH ID | M0068542 |
Synonyms (54)
| Synonym |
|---|
| c24h16as2o3 |
| diphenoxarsin-10-yl oxide |
| bis(10-phenoxarsinyl)oxide |
| hsdb 6375 |
| bis(10-phenoxyarsinyl) oxide |
| vinyzene bp 5-2 |
| obpa |
| 10,10'-oxybis-10h-phenoxarsine |
| 10-10' oxybisphenoxyarsine |
| einecs 200-377-3 |
| phenoxyarsine, 10,10'-oxybis- |
| vinyzene bp 5 |
| bis(10-phenoxarsyl) oxide |
| did 47 |
| vinadine |
| phenoxarsine oxide |
| phenoxaksine oxide |
| vinyzene (pesticide) |
| phenoxarsine, 10,10'-oxydi- |
| 10,10'-oxydiphenoxarsine |
| 10,10'-bis(phenoxyarsinyl) oxide |
| 10h-phenoxarsine, 10,10'-oxybis- |
| durotex |
| 10,10'-oxidiphenoxarsine |
| 10,10'-oxybisphenoxy-arsine |
| vinyzene sb 1 |
| bis(phenoxarsin-10-yl) ether |
| 10,10'-oxybisphenoxarsine |
| sa 546 |
| brn 0055641 |
| bis(10-phenoxarsyl)oxide |
| 10-phenoxarsinin-10-yloxyphenoxarsinine |
| 58-36-6 |
| 10,10-oxybisphenoxarsine |
| 2-27-00-00948 (beilstein handbook reference) |
| 1r0gee9l5z , |
| vinyzene bs 1 |
| unii-1r0gee9l5z |
| 10,10'-oxydiphenoxarsine [mi] |
| bis(phenoxarsin-10-yl)ether |
| vinyzene sb-1 |
| 10,10'-oxybis(phenoxarsine) |
| AKOS022185378 |
| SCHEMBL203388 |
| 10-(10h-phenoxarsin-10-yloxy)-10h-phenoxarsine # |
| estabex abf |
| bis(10-phenoxarsinyl) oxide |
| DTXSID0032443 |
| 10,10'-oxybis(10h-phenoxarsinine) |
| FT-0706583 |
| Q3376217 |
| H11760 |
| A915131 |
| CS-0161828 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (7)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 12.21
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.21) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||